食管压导向PEEP滴定 vs 经验性高PEEP-Fio2策略对中重度ARDS患者死亡和无机械通气天数的影响:一项随机临床试验
这项在北美14家医院进行的2期随机临床试验纳入200例中重度ARDS患者(Pao2:Fio2 ≤200 mm Hg),随机接受食管压导向PEEP(n=102)或经验性高PEEP-Fio2策略(n=98),均接受低潮气量通气。主要终点为死亡和幸存者无机械通气天数的排序复合评分,两组无显著差异(食管压导向PEEP更优概率49.6% [95%CI 41.7%-57.5%];P=.92)。28天死亡率分别为32.4%和30.6%(风险差1.7% [95%CI -11.1%-14.6%];P=.88),幸存者无机械通气天数中位数分别为22天和21天(中位数差0 [95%CI -1-2]天;P=.85)。食管压导向PEEP组接受挽救治疗的比例显著更低(3.9% vs 12.2%;风险差-8.3% [95%CI -15.8%--0.8%];P=.04)。作者结论认为这些发现不支持在ARDS中进行食管压导向PEEP滴定。
要点
- 中重度ARDS(Pao2:Fio2 ≤200 mm Hg)患者中,食管压导向PEEP与经验性高PEEP-Fio2策略相比,主要复合终点无显著差异(更优概率49.6% [95%CI 41.7%-57.5%];P=.92)。
- 28天死亡率:食管压导向PEEP组32.4%(33/102) vs 经验性高PEEP-Fio2组30.6%(30/98),风险差1.7% [95%CI -11.1%-14.6%];P=.88。
- 幸存者无机械通气天数中位数:食管压导向PEEP组22天 vs 经验性高PEEP-Fio2组21天,中位数差0天 [95%CI -1-2]天;P=.85。
- 食管压导向PEEP组接受挽救治疗的比例显著低于经验性高PEEP-Fio2组(3.9% [4/102] vs 12.2% [12/98];风险差-8.3% [95%CI -15.8%--0.8%];P=.04)。
- 作者结论:这些发现不支持在ARDS中进行食管压导向PEEP滴定。
适用人群与场景
- 年龄16岁及以上、接受机械通气的中重度ARDS患者(Pao2:Fio2 ≤200 mm Hg),来自北美14家医院。
诊断标准与关键阈值
- 中重度ARDS定义:Pao2:Fio2 ≤200 mm Hg。
处置流程与药物剂量
- 所有参与者接受低潮气量通气。
- 食管压导向PEEP组:根据食管压(PES,估测胸膜压)滴定PEEP(n=102)。
- 经验性高PEEP-Fio2组:采用经验性高PEEP-Fio2策略(n=98)。
研究设计与关键结果
- 2期随机临床试验,北美14家医院,纳入200例中重度ARDS患者(平均[SD]年龄56[16]岁;46%女性),2012年10月31日至2017年9月14日入组,长期随访于2018年7月30日完成。
- 主要终点为死亡和幸存者至第28天无机械通气天数的排序复合评分:食管压导向PEEP更优概率49.6%(95%CI 41.7%-57.5%);P=.92,组间无显著差异。
- 28天死亡率:食管压导向PEEP组33/102(32.4%) vs 经验性高PEEP-Fio2组30/98(30.6%);风险差1.7%(95%CI -11.1%-14.6%);P=.88。
- 幸存者无机械通气天数:食管压导向PEEP组中位数22天(四分位距15-24) vs 经验性高PEEP-Fio2组21天(四分位距16.5-24);中位数差0天(95%CI -1-2);P=.85。
- 接受挽救治疗:食管压导向PEEP组4/102(3.9%) vs 经验性高PEEP-Fio2组12/98(12.2%);风险差-8.3%(95%CI -15.8%--0.8%);P=.04。
- 其他7个预设次要临床终点均无显著差异。
- 不良事件:大体气压伤在食管压导向PEEP组发生6例,经验性高PEEP-Fio2组发生5例。
证据类型、等级与局限
- 证据类型:2期随机临床试验。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者结论认为,这些发现不支持在ARDS中进行食管压导向PEEP滴定。
- 原文未据此给出其他推荐。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
IMPORTANCE: Adjusting positive end-expiratory pressure (PEEP) to offset pleural pressure might attenuate lung injury and improve patient outcomes in acute respiratory distress syndrome (ARDS).
OBJECTIVE: To determine whether PEEP titration guided by esophageal pressure (PES), an estimate of pleural pressure, was more effective than empirical high PEEP-fraction of inspired oxygen (Fio2) in moderate to severe ARDS.
DESIGN, SETTING, AND PARTICIPANTS: Phase 2 randomized clinical trial conducted at 14 hospitals in North America. Two hundred mechanically ventilated patients aged 16 years and older with moderate to severe ARDS (Pao2:Fio2 ≤200 mm Hg) were enrolled between October 31, 2012, and September 14, 2017; long-term follow-up was completed July 30, 2018.
INTERVENTIONS: Participants were randomized to PES-guided PEEP (n = 102) or empirical high PEEP-Fio2 (n = 98). All participants received low tidal volumes.
MAIN OUTCOMES AND MEASURES: The primary outcome was a ranked composite score incorporating death and days free from mechanical ventilation among survivors through day 28. Prespecified secondary outcomes included 28-day mortality, days free from mechanical ventilation among survivors, and need for rescue therapy.
RESULTS: Two hundred patients were enrolled (mean [SD] age, 56 [16] years; 46% female) and completed 28-day follow-up. The primary composite end point was not significantly different between treatment groups (probability of more favorable outcome with PES-guided PEEP: 49.6% [95% CI, 41.7% to 57.5%]; P = .92). At 28 days, 33 of 102 patients (32.4%) assigned to PES-guided PEEP and 30 of 98 patients (30.6%) assigned to empirical PEEP-Fio2 died (risk difference, 1.7% [95% CI, -11.1% to 14.6%]; P = .88). Days free from mechanical ventilation among survivors was not significantly different (median [interquartile range]: 22 [15-24] vs 21 [16.5-24] days; median difference, 0 [95% CI, -1 to 2] days; P = .85). Patients assigned to PES-guided PEEP were significantly less likely to receive rescue therapy (4/102 [3.9%] vs 12/98 [12.2%]; risk difference, -8.3% [95% CI, -15.8% to -0.8%]; P = .04). None of the 7 other prespecified secondary clinical end points were significantly different. Adverse events included gross barotrauma, which occurred in 6 patients with PES-guided PEEP and 5 patients with empirical PEEP-Fio2.
CONCLUSIONS AND RELEVANCE: Among patients with moderate to severe ARDS, PES-guided PEEP, compared with empirical high PEEP-Fio2, resulted in no significant difference in death and days free from mechanical ventilation. These findings do not support PES-guided PEEP titration in ARDS.
TRIAL REGISTRATION: ClinicalTrials.gov Identifier NCT01681225.
参考来源
- Beitler JR, Sarge T, Banner-Goodspeed VM, et al. Effect of Titrating Positive End-Expiratory Pressure (PEEP) With an Esophageal Pressure-Guided Strategy vs an Empirical High PEEP-Fio2 Strategy on Death and Days Free From Mechanical Ventilation Among Patients With Acute Respiratory Distress Syndrome: A Randomized Clinical Trial. JAMA. 2019. PMID: 30776290. doi:10.1001/jama.2019.0555
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。